GFS GLOBALFOUNDRIES INC

U.S. Government Accredits GlobalFoundries to Manufacture Trusted Semiconductors at New York Facility

U.S. Government Accredits GlobalFoundries to Manufacture Trusted Semiconductors at New York Facility

Securely manufactured chips to be used in DoD systems on land, air, sea, and in space

MALTA, N.Y., May 30, 2023 (GLOBE NEWSWIRE) -- The U.S. Department of Defense (DoD), through the Defense Microelectronics Activity (DMEA), Trusted Access Program Office (TAPO), has accredited GlobalFoundries’ (Nasdaq: GFS) (GF) advanced manufacturing facility in Malta, New York, as a Category 1A Trusted Supplier with the ability to manufacture secure semiconductors for a range of critical aerospace and defense applications.

The latest milestone in the longstanding partnership between the DoD and GF, the accreditation was enabled by GF’s ability to meet DoD requirements for having stringent security processes, equipment, and oversight in place to accept and protect sensitive information and manufacture Trusted chips in a way that ensures they are secure and uncompromised. These securely manufactured chips include those manufactured on GF’s most advanced 12nm FinFET technologies, and will be used in DoD systems on land, air, sea, and in space.

“The secure manufacturing of semiconductors is critical to safeguarding the confidentiality, integrity, and reliability of the technology that powers our modern world, and nowhere is this more important than aerospace, defense, and critical infrastructure systems,” said Dr. Thomas Caulfield, president and CEO of GF. “We are proud to deepen our relationship with the Defense Department, and to receive DMEA accreditation at our New York manufacturing facility. GF’s differentiated chip technologies provide optimized performance for critical DoD systems, and we are uniquely positioned by our ability to provide secure semiconductor manufacturing at scale.”

Dr. Nicholas Martin, DMEA Director, said: “This accreditation at the Malta site will enable the Department to have access to the most advanced ASIC technology node available from a DMEA accredited Trusted Supplier. Accrediting GlobalFoundries to manufacture our country’s sensitive chips strengthens the domestic microelectronics industrial base and our nation’s efforts to fortify its semiconductor supply chain for national and economic security. Trusted Supplier accreditation continues to be a benchmark in semiconductor assurance and will ensure the DoD has reliable access to a range of securely manufactured chips it needs for its defense systems and is the latest collaboration in the longstanding partnership between the DoD and GF to provide silicon-based semiconductors for defense and aerospace applications.”

In 2022, the DoD, through the Manufacturing Capability Expansion and Investment Prioritization (MCEIP) Directorate, entered a $117 million agreement with GF to provide a strategic supply of U.S.-made semiconductors built in Malta, New York, on GF’s differentiated 45nm SOI platform. This accreditation adds to GF’s New York Facility’s compliance with U.S. International Traffic in Arms Regulations (ITAR) and highly restrictive Export Control Classification Numbers under the Export Administration Regulations (EAR). GF employs approximately 2,500 people in Malta, New York, and has invested more than $15 billion in the facility. GF also manufactures Trusted semiconductor chips for the DoD at its facility in Vermont.

About GF

GlobalFoundries (GF) is one of the world’s leading semiconductor manufacturers. GF is redefining innovation and semiconductor manufacturing by developing and delivering feature-rich process technology solutions that provide leadership performance in pervasive high growth markets. GF offers a unique mix of design, development and fabrication services. With a talented and diverse workforce and an at-scale manufacturing footprint spanning the U.S., Europe and Asia, GF is a trusted technology source to its worldwide customers. For more information, visit .

©GlobalFoundries Inc., GF, GlobalFoundries, the GF logos and other GF marks are trademarks of GlobalFoundries Inc. Or its subsidiaries. All other trademarks are the property of their respective owners.

Forward-looking Information

This news release may contain forward-looking statements, which involve risks and uncertainties. Readers are cautioned not to place undue reliance on any of these forward-looking statements. These forward-looking statements speak only as of the date hereof. GF undertakes no obligation to update any of these forward-looking statements to reflect events or circumstances after the date of this news release or to reflect actual outcomes, unless required by law. 

Media Contact:

Michael Mullaney

 



EN
30/05/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on GLOBALFOUNDRIES INC

Wedbush Research
  • Wedbush Research
UBI UBISOFT ENTERTAINMENT SA
XNCR XENCOR INC.
XENE XENON PHARMACEUTICALS INC
WDC WESTERN DIGITAL CORPORATION
VYGR VOYAGER THERAPEUTICS INC.
TTWO TAKE-TWO INTERACTIVE SOFTWARE INC.
TSLA TESLA INC
SIMON SILICON MOTION TECHNOLOGY CORPORATION SPONSORED ADR
RARE ULTRAGENYX PHARMACEUTICAL INC.
PSTG PURE STORAGE INC. CLASS A
NVDA NVIDIA CORPORATION
NVCR NOVOCURE LTD.
NTAP NETAPP INC.
NBIX NEUROCRINE BIOSCIENCES INC.
MU MICRON TECHNOLOGY INC.
KURA KURA ONCOLOGY INC.
INTC INTEL CORPORATION
WELL WELLTOWER INC.
GME GAMESTOP CORP. CLASS A
GERN GERON CORP.
FB FACEBOOK INC. CLASS A
FATE FATE THERAPEUTICS INC
CTMX CYTOMX THERAPEUTICS INC.
BPMC BLUEPRINT MEDICINES CORP.
BMRN BIOMARIN PHARMACEUTICAL INC.
BIIB BIOGEN INC.
ASND ASCENDIS PHARMA A/S SPONSORED ADR
ARDX ARDELYX INC
CDR CD PROJEKT S.A.
FRX_CN FENNEC PHARMACEUTICALS
7974 NINTENDO CO. LTD.
2330 TAIWAN SEMICONDUCTOR MANUFACTURING CO. LTD.
2303 UNITED MICROELECTRONICS CORP.
EA ELECTRONIC ARTS INC.
ANAB ANAPTYSBIO INC.
ARGX ARGENX ADS
MRSN MERSANA THERAPEUTICS
VTR VENTAS INC.
ISR ISORAY
AMD ADVANCED MICRO DEVICES INC.
AAPL APPLE INC.
MSFT MICROSOFT CORPORATION
APLS APELLIS PHARMACEUTICALS
DNLI DENALI THERAPEUTICS INC
RCUS ARCUS BIOSCIENCES
SRRK SCHOLAR ROCK HOLDING CORPORATION
KNSA KINIKSA PHARMACEUTICALS
REPL REPLIMUNE GROUP
ARVN ARVINAS HOLDING
YMAB Y-MABS THERAPEUTICS
STRO SUTRO BIOPHARMA
DELL DELL TECHNOLOGIES INC CLASS C
STOK STOKE THERAPEUTICS
IGMS IGM BIOSCIENCES
SWTX SPRINGWORKS THERAPEUTICS
SMCI SUPER MICRO COMPUTER
IDYA INC.
PASG IDEAYA BIOSCIENCES
BDTX PASSAGE BIO
ACET BLACK DIAMOND THERAPEUTICS
KROS ADICET BIO INC
ITOS KEROS THERAPEUTICS
ZNTL ITEOS THERAPEUTICS
LRMR ZENTALIS PHARMACEUTICALS
PRAX LARIMAR THERAPEUTICS INC
U PRAXIS PRECISION MEDICINES
TVTX UNITY SOFTWARE
VRDN TRAVERE THERAPEUTICS INC
DAWN VIRIDIAN THERAPEUTICS INC
ELEV DAY ONE BIOPHARMACEUTICALS INC
MRVL ELEVATION ONCOLOGY
STX MARVELL TECHNOLOGY INC
APP SEAGATE TECHNOLOGY HLDGS PLC
ATXS APPLOVIN CORP
GFS ASTRIA THERAPEUTICS INC
GMTX GLOBALFOUNDRIES INC
VIGL GEMINI THERAPEUTICS INC
TYRA VIGIL NEUROSCIENCE INC
EWTX TYRA BIOSCIENCES INC
DDI EDGEWISE THERAPEUTICS INC
APGE DOUBLEDOWN INTERACTIVE CO LTD
SKLZ APOGEE THERAPEUTICS INC
EMBRAC B SKILLZ INC
MXL-US EMBRACER GROUP AB
MAXLINEAR
INC.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch